专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20110082053A1 Molecular Rectifiers Comprising Diamondoids 审中-公开
标题翻译：包括金刚石的分子整流器
公开(公告)号：US20110082053A1
公开(公告)日：2011-04-07
申请号：US12865391
申请日：2009-01-30
申请人： Wanli Yang , Zhi-Xun Shen , Harindran C. Manoharan , Nicholas A. Melosh , Michael A. Kelly , Andrey A. Fokin , Peter R. Schreiner , Jason C. Randel
发明人： Wanli Yang , Zhi-Xun Shen , Harindran C. Manoharan , Nicholas A. Melosh , Michael A. Kelly , Andrey A. Fokin , Peter R. Schreiner , Jason C. Randel
IPC分类号： C40B40/04 , C07C255/47 , C07C61/12 , C07C251/18 , C07C211/38 , C07C321/22 , C07C35/22 , C07C205/05 , C07C23/18 , C07C13/615 , B82Y99/00
CPC分类号： H01L51/0047 , B82Y10/00 , H01L51/0508 , H01L51/0583 , H01L51/0595 , H01L51/42 , H01L51/50 , Y02E10/549
摘要： Provided is a molecular rectifier comprised of a diamondoid molecule and an electron acceptor attached to the diamondoid molecule. The electron acceptor is generally an electron accepting aromatic species which is covalently attached to the diamondoid.
摘要翻译：提供了由金刚石分子和连接到金刚石分子的电子受体组成的分子整流体。电子受体通常是共价连接到金刚石的受电子的芳族物质。

2. 发明申请

US20110308605A1 Applicable Fluorescence of Diamondoids 审中-公开
标题翻译：金刚石的适用荧光
公开(公告)号：US20110308605A1
公开(公告)日：2011-12-22
申请号：US12865390
申请日：2009-01-30
申请人： Zhi Liu , Will Clay , Michael A. Kelly , Nicholas A. Melosh , Zhi-Xun Shen , Andrey A. Fokin , Peter R. Schreiner
发明人： Zhi Liu , Will Clay , Michael A. Kelly , Nicholas A. Melosh , Zhi-Xun Shen , Andrey A. Fokin , Peter R. Schreiner
IPC分类号： H01L31/0216 , C07C13/615 , H05B33/14
CPC分类号： H05B33/14 , C09K11/06 , C09K2211/1007 , H01L31/02322 , H01L31/055 , H01L51/5012 , Y02B20/181 , Y02E10/52
摘要： Provided is a fluorescent diamondoid material which when energized, either by an electric field or by high energy radiation, emits light. The light emitted is generally in the visible range. The diamondoid material can be fine tuned by internal or external doping. The fluorescent materials comprised of diamondoids, have applications in several fields. One application is in solar cells where these materials can be used to improve the overall efficiency of the device. A second application is in indoor lighting where the materials can be used to efficiently produce white light. This can be done by either using the material as a fluorescent medium for a UV light source, in an electroluminescence device, or by using the material as part of an organic light emitting diode (OLED).
摘要翻译：提供了一种荧光金刚石材料，当通过电场或通过高能量辐射被激发时，其发光。发出的光通常在可见光范围内。金刚石材料可以通过内部或外部掺杂进行微调。由金刚石组成的荧光材料在几个领域都有应用。一种应用在太阳能电池中，其中可以使用这些材料来提高器件的整体效率。第二个应用是室内照明，其中材料可以用于有效地产生白光。这可以通过使用材料作为UV光源的荧光介质，电致发光器件，或通过使用该材料作为有机发光二极管（OLED）的一部分来完成。

3. 发明授权

US08138375B2 Method for producing 1-formamido-3,5-dimethyladamantane 有权
标题翻译： 1-甲酰氨基-3,5-二甲基金刚烷的制备方法
公开(公告)号：US08138375B2
公开(公告)日：2012-03-20
申请号：US12224575
申请日：2007-02-20
申请人： Peter R. Schreiner , Andrey A. Fokin , Lukas Wanka , Derek M. Wolfe
发明人： Peter R. Schreiner , Andrey A. Fokin , Lukas Wanka , Derek M. Wolfe
IPC分类号： C07C231/08 , C07C233/57
CPC分类号： C07C231/08 , C07C2603/74 , C07C233/03
摘要： The invention relates to a method for producing 1-formamido-3,5-dimethyladamantane in only two reaction steps by direct formamide formation of 1,3-dimethyladamantane, the 1,3-dimethyladamantane being reacted with formamide in concentrated acids.
摘要翻译：本发明涉及通过直接甲酰胺形成1,3-二甲基金刚烷，1,3-二甲基金刚烷与浓缩酸中的甲酰胺反应，仅在两个反应步骤中生产1-甲酰氨基-3,5-二甲基金刚烷的方法。

4. 发明申请

US20100036153A1 Method for Producing Substituted Diamantanes 失效
标题翻译：生成取代的金刚烷的方法
公开(公告)号：US20100036153A1
公开(公告)日：2010-02-11
申请号：US12086058
申请日：2006-12-04
申请人： Peter R. Schreiner , Andrey A. Fokin
发明人： Peter R. Schreiner , Andrey A. Fokin
IPC分类号： C07C35/44 , C07C239/08 , C07C233/08 , C07C61/125 , C07C69/753
CPC分类号： C07C203/08 , C07C29/12 , C07C51/353 , C07C67/11 , C07C2603/90 , C07C35/44 , C07C61/135 , C07C69/013 , C07C69/14
摘要： The invention at hand provides at least dinitroxylated diamantanes. In addition, it provides methods for producing substituted diamantanes with high yields and selectivity.According to the invention, dinitroxylated diamantanes are suitable for being reacted with nucleophiles to form the corresponding disubstituted diamantanes. Surprisingly, it was discovered that at least dinitroxylated or hydroxylated diamantanes are rearranged in the presence of a strong acid, creating at least 4,9-nitroxylated or hydroxylated diamantanes. On the basis of this, 4,9-substituted diamantanes are able to be produced in a targeted manner by reaction with further nucleophiles.Thus, the invention at hand provides the following methods according to the present invention for producing at least disubstituted diamantanes: a) at least dinitroxylation, followed by the substitution of all nitroxy groups by a nucleophile or b) at least dinitroxylation, subsequent rearrangement in the presence of a strong acid, after realised rearrangement all nitroxy groups are replaced by a nucleophile or c) at least dinitroxylation, subsequent reaction with water (as nucleophile), rearrangement of the at least dihydroxylated compound in the presence of a strong acid, after realised rearrangement all hydroxy groups are replaced by another nucleophile.
摘要翻译：本发明至少提供二硝基甲酰化的二金刚烷。此外，它提供了以高产率和选择性生产取代的二金刚烷的方法。根据本发明，二硝基氧化的二金刚烷适于与亲核试剂反应以形成相应的二取代的二金刚烷。令人惊奇的是，发现在强酸存在下重新排列了二硝基氧化或羟基化的二金刚烷，产生了至少4,9-氨基氧化或羟基化的金刚烷。基于此，4,9-取代的二金刚烷可以通过与另外的亲核试剂反应而以目标方式制备。因此，本发明提供了根据本发明的用于生产至少二取代的二金刚烷的以下方法：a）至少二硝基甲酰化，然后用亲核试剂取代所有硝基，或b）至少二硝基甲酰化，随后在强酸的存在，在实现重排之后，所有的硝基都被亲核试剂取代，或c）至少二硝基甲酰化，随后与水（作为亲核试剂）反应，在强酸存在下重排至少二羟基化的化合物，重排所有羟基被另一个亲核试剂取代。

5. 发明授权

US08716539B2 Method for producing substituted diamantanes 失效
标题翻译：取代的二金刚烷的制备方法
公开(公告)号：US08716539B2
公开(公告)日：2014-05-06
申请号：US12086058
申请日：2006-12-04
申请人： Peter R. Schreiner , Andrey A. Fokin
发明人： Peter R. Schreiner , Andrey A. Fokin
IPC分类号： C07C13/28
CPC分类号： C07C203/08 , C07C29/12 , C07C51/353 , C07C67/11 , C07C2603/90 , C07C35/44 , C07C61/135 , C07C69/013 , C07C69/14
摘要： Dinitroxylated diamantanes are suitable for being reacted with nucleophiles to form the corresponding disubstituted diamantanes. Surprisingly, at least dinitroxylated or hydroxylated diamantanes are rearranged in the presence of a strong acid and at least 4,9-nitroxylated or hydroxylated diamantanes are created. On this basis, 4,9-substituted diamantanes are able to be produced in a targeted manner by reaction with further nucleophiles. Methods for producing at least disubstituted diamantanes include: (a) at least dinitroxylation, followed by the substitution of all nitroxy groups by a nucleophile; or (b) at least dinitroxylation, the subsequent rearrangement in the presence of a strong acid, after realized rearrangement all nitroxy groups are replaced by a nucleophile; or (c) at least dinitroxylation, then subsequent reaction with water (as nucleophile), and rearrangement of the at least dihydroxylated compound in the presence of a strong acid, all hydroxy groups being replaced by another nucleophile in the event of a successful rearrangement.
摘要翻译：二硝基甲酰基二金刚烷适于与亲核试剂反应形成相应的二取代二金刚烷。令人惊讶的是，至少在强酸存在下重新排列二硝基甲氧基化或羟基化的金刚烷，并产生至少4,9-硝酰化或羟基化的二金刚烷。在此基础上，能够通过与另外的亲核试剂反应，以目标方式制备4,9-取代的二金刚烷。生产至少二取代的二金刚烷的方法包括：（a）至少二硝基甲酰化，然后用亲核试剂代替全部硝基; 或（b）至少二硝基甲酰化，随后在强酸存在下的重排，在实现重排之后，所有的硝酰基被亲核试剂替代; 或（c）至少二硝基甲酰化，然后随后与水（作为亲核试剂）反应，并且在强酸存在下重排至少二羟基化的化合物，在成功重排的情况下，所有羟基都被另一个亲核试剂取代。

6. 发明申请

US20090299097A1 Method for Producing 1-Formamido-3,5-Dimethyladamantane 有权
标题翻译： 1-甲酰氨基-3,5-二甲基金刚烷的制备方法
公开(公告)号：US20090299097A1
公开(公告)日：2009-12-03
申请号：US12224575
申请日：2007-02-20
申请人： Peter R. Schreiner , Andrey A. Fokin , Lukas Wanka , Derek M. Wolfe
发明人： Peter R. Schreiner , Andrey A. Fokin , Lukas Wanka , Derek M. Wolfe
IPC分类号： C07C233/03 , C07C211/38
CPC分类号： C07C231/08 , C07C2603/74 , C07C233/03
摘要： The invention relates to a method for producing 1-formamido-3,5-dimethyladamantane in only two reaction steps by direct formamide formation of 1,3-dimethyladamantane, the 1,3-dimethyladamantane being reacted with formamide in concentrated acids.
摘要翻译：本发明涉及通过直接甲酰胺形成1,3-二甲基金刚烷，1,3-二甲基金刚烷与浓缩酸中的甲酰胺反应，仅在两个反应步骤中生产1-甲酰氨基-3,5-二甲基金刚烷的方法。

7. 发明申请

US20090299096A1 Amidoadamantanes and Method for Producing the Same 审中-公开
标题翻译：酰胺金刚烷及其制备方法
公开(公告)号：US20090299096A1
公开(公告)日：2009-12-03
申请号：US12224545
申请日：2007-02-20
申请人： Peter R. Schreiner , Andrey A. Fokin , Lukas Wanka , Derek M. Wolfe
发明人： Peter R. Schreiner , Andrey A. Fokin , Lukas Wanka , Derek M. Wolfe
IPC分类号： C07C233/03 , C07C231/08
CPC分类号： C07C233/03 , C07C231/08 , C07C2603/74
摘要： The invention relates to 1-formamido-adamantane derivatives of formula (I), which carry the substituents R1, R2 or R3 in 3, 5 and/or 7 position, the substituents being defined as follows: hydrogen, a linear or branched alkyl, alkenyl or alkinyl group with up to 6 C atoms, an aliphatic or aromatic, cyclic or heterocyclic hydrocarbon group with up to 10 carbon atoms, and formamides of hydrocarbons from the group of diamondoids, for example diamantane, triamantane, tetramantane and pentamantane, however, with the exception of 1-formamido-3,5-dimethyladamantane. The invention also relates to a method for the direct formation of formamide or acetamide of adamantane, adamantane derivatives with the aforementioned definition of substituents or of a hydrocarbon from the group of diamondoids, characterized by reacting the adamantane, the adamantane derivative or the diamondoid with formamide, acetamide or acetonitrile in concentrated acids, while avoiding SO3 containing sulfuric acid or 100% azotic acid.
摘要翻译：本发明涉及式（I）的1-甲酰氨基 - 金刚烷衍生物，其在3,5和/或7位上具有取代基R 1，R 2或R 3，取代基定义如下：氢，直链或支链烷基，具有至多6个C原子的链烯基或炔基，具有至多10个碳原子的脂族或芳族，环状或杂环烃基，以及来自金刚石类的例如金刚烷，三金刚烷，四聚烷和五金刚烷烃的甲酰胺，除了1-甲酰氨基-3,5-二甲基金刚烷外。本发明还涉及直接形成甲酰胺或乙酰胺的金刚烷，金刚烷衍生物，具有上述定义的取代基或来自金刚石类的烃，其特征在于使金刚烷，金刚烷衍生物或金刚石与甲酰胺反应，乙酰胺或乙腈在浓缩酸中，同时避免SO 3含硫酸或100％偶氮酸。

8. 发明申请

US20130165625A1 PEPTIDES INCORPORATING 3-AMINOADAMANTANE CARBOXYLIC ACIDS ENHANCE SYNAPTIC PLASTICITY AND ACT AS NEUROGENIC AGENTS 审中-公开
标题翻译：含有三氨基甲酸酯类羧酸的肽类增强作为神经细胞代谢物的合成塑料和作用
公开(公告)号：US20130165625A1
公开(公告)日：2013-06-27
申请号：US13704819
申请日：2011-06-22
申请人： Peter R. Schreiner , Lukas Wanka
发明人： Peter R. Schreiner , Lukas Wanka
IPC分类号： C07K7/56 , C07K7/02
CPC分类号： C07K7/02 , C07K7/56
摘要： The disclosed invention relates to peptides incorporating 3-aminoadamantane-1-carboxylic acids. These peptides are disclosed as surprisingly possessing neurogenic and neurotrophic properties. These pharmacological activities can advantageously be utilized for restoring or maintaining neuronal function in the CNS. In particular, the compounds can be used for treatment and prophylaxis of neurodegenerative diseases, e. g., Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, as well as in post-acute traumatic brain injury, or cerebral ischemia.
摘要翻译：所公开的发明涉及结合3-氨基金刚烷-1-羧酸的肽。公开这些肽令人惊奇地具有神经源性和神经营养性质。这些药理活性可有利地用于恢复或维持CNS中的神经元功能。特别地，这些化合物可用于治疗和预防神经变性疾病，例如，例如阿尔茨海默病，帕金森病，亨廷顿病，肌萎缩性侧索硬化，以及急性创伤性脑损伤或脑缺血。

9. 发明申请

US20110124912A1 MONOETHERIFIED DIOLS OF DIAMONDOIDS 审中-公开
标题翻译：单一的DIAMONDOID DIOLS
公开(公告)号：US20110124912A1
公开(公告)日：2011-05-26
申请号：US12996399
申请日：2009-06-02
申请人： Peter R. Schreiner , Hartmut Schwertfeger
发明人： Peter R. Schreiner , Hartmut Schwertfeger
IPC分类号： C07C227/02 , C07C43/196 , C07C41/09 , C07C231/06 , C07C213/02
CPC分类号： C07C41/09 , C07C43/196 , C07C215/44 , C07C217/52 , C07C229/50 , C07C233/23 , C07C2603/90 , Y02P20/55
摘要： The invention at hand describes functionalized diols of diamondoids, in which one of the two hydroxy groups is masked by a protective group, as well as methods for producing these functionalized diols. The protective group is a group —CHR1R2, wherein R1 and R2 stand for alkyl groups and the protective group comprises at least one halogen atom. The monoethers of the diamondoid diols according to the present invention are produced by reacting the diamondoid diol with a halogenated alcohol CHOHR1R2 in the presence of a catalyst acid.The monoetherified diols allow for the targeted production of derivatives of diamondoids, for example, of the corresponding aminoalcohols and aminocarboxylic acids. For that purpose, the diamondoid monoether is reacted in a first step with a halogen nitrile in a Ritter reaction to the corresponding monoether amide. From this monoether amide, the corresponding aminoalcohol can be produced by reacting the protective group —CHR1R2 first with trifluoroacetic acid to the alkanoyloxy group and by subsequently obtaining the aminoalcohol by reaction with thiourea, ethanol and glacial acetic acid.The aminoalcohol can be reacted with a sulfuric acid/formic acid or oleum/formic acid to the corresponding aminocarboxylic acid.The amino, hydroxy and carboxylic groups of the diamondoids can be converted into many other functional groups.
摘要翻译：本发明描述了金刚石的官能化二醇，其中两个羟基中的一个被保护基掩蔽，以及制备这些官能化二醇的方法。保护基是基团-CHR1R2，其中R1和R2代表烷基，保护基包括至少一个卤素原子。根据本发明的金刚石二醇的单醚通过在催化剂酸的存在下使类金刚石二醇与卤代醇CHOHR1R2反应来制备。单醚化的二醇允许目标生成类金刚石衍生物，例如相应的氨基醇和氨基羧酸。为此，金刚石单醚在第一步中与Ritter反应中的卤素腈与相应的单醚酰胺反应。从该单醚酰胺可以通过使保护基-CHR1R2与三氟乙酸首先与烷酰氧基反应，随后通过与硫脲，乙醇和冰醋酸反应得到氨基醇来制备相应的氨基醇。氨基醇可以与硫酸/甲酸或发烟硫酸/甲酸反应至相应的氨基羧酸。金刚石的氨基，羟基和羧基可以转化为许多其他官能团。

10. 发明申请

US20080275112A1 Invention Concerning Aminoadamantane Compounds 审中-公开
标题翻译：关于氨基金刚烷化合物的发明
公开(公告)号：US20080275112A1
公开(公告)日：2008-11-06
申请号：US11658172
申请日：2005-07-22
申请人： Peter R. Schreiner , Lukas Wanka
发明人： Peter R. Schreiner , Lukas Wanka
IPC分类号： A61K31/27 , C07C233/08 , C07C211/38 , C07C23/38 , A61K31/16 , A61K31/025 , A61P25/00 , A61P33/00 , A61K31/215 , A61K31/196 , A61K31/13 , C07C61/135 , C07C271/24 , C07C229/50
CPC分类号： C07C211/38 , C07C229/50 , C07C231/06 , C07C231/12 , C07C233/06 , C07C233/14 , C07C233/52 , C07C237/24 , C07C275/26 , C07C2603/18 , C07C2603/74
摘要： The present invention describes 1-aminoadamantane derivatives and 3-aminoadamantane-1-carboxylic derivatives in which the 5- or 7-position of the basic adamantane structure can be optionally substituted, methods for the production of the compounds based on the present invention, and methods for the coupling of the monomeric 3-aminoadamantane-1-carboxylic derivatives thus obtained to oligomers. The compounds based on the present invention are suitable for the utilisation as antiviral active ingredients, artificial ion channels, as well as for the therapy, diagnostics and prophylaxis of diseases in which a dysfunction of the GABA system occurs.
摘要翻译：本发明描述了1-氨基金刚烷衍生物和3-氨基金刚烷-1-羧酸衍生物，其中碱金属金刚烷结构的5-或7-位可以任选被取代，制备基于本发明的化合物的方法和由此得到的单体3-氨基金刚烷-1-羧酸衍生物与低聚物偶联的方法。基于本发明的化合物适合用作抗病毒活性成分，人造离子通道，以及用于治疗，诊断和预防发生GABA系统功能障碍的疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式